Both in Biotechnology
Jasper Therapeutics vs BioStem Technologies
Over the past year JSPR returned −22.6% and BSEM returned −73.3%; their daily moves had a correlation of 0.30.
JSPR −22.6% BSEM −73.3%Growth of $1, one year, split-adjusted
| Metric | JSPR | BSEM |
|---|---|---|
| Price | $0.5111 | $1.15 |
| Market cap | $17.0M | $21.5M |
| Today | +6.48% | 0.00% |
| 1 month | −8.7% | −53.4% |
| 6 months | −46.0% | — |
| Year to date | −72.1% | — |
| 1 year | −75.7% | — |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $7.3M | — |
| Dividend yield | — | — |
| Volatility (60d) | 75.7% | — |
| Short % of float | 22.6% | 2.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).